Consultant – MedicalOncology & Hemato Oncology MBBS., DNB - General Medicine, DNB – Medical Oncology MRCP (UK) - Medical Oncology (SCE) Hyderabad Experience: 4 Years Timings : Mon-Sat: 10am-5pm
About Doctor:
Breast Cancer
Lung Cancer
Gastro Intestinal Cancers
Head and Neck Cancer
Genito Urinary cancers
Hematological Malignancies
Bone cancer and soft tissue sarcomas
Targeted Therapy
Immuno Therapy
Palliative & Supportive Care for Advanced Cancer
Bone Marrow Aspiration and Biopsy
Lumbar puncture and Intrathecal therapy
Hereditary cancers – Screening and genetic counselling
Precision Oncology
Familial and hereditary cancer treatment
Cancer screening with genetic counselling
Senior Registrar in Medical Oncology in Apollo Indraprastha Hospitals in Delhi NCR – 3 years
Senior Resident in Medical Oncology in at P D Hinduja National Hospitals and Research Center, Mumbai ,Maharastra– 1 year
Membership of Royal College of Physicians of United Kingdom in Medical Oncology - MRCP (UK) - Speciality Certificate Examination -2021
Doctorate of National Board - Medical Oncology - Apollo Indraprastha Hospitals and Research Center, New Delhi
Diplomat of National Board - General Medicine - P.D.Hinduja National Hospitals and Research Center, Mumbai
MBBS - Bhaskar Medical College and Research Center, Hyderabad
Merit Award by European Society Of Medical Oncology- Immuno Oncology Conference At Geneva, Switzerland 2020 (Virtual) For Best Abstract
Travel Grant by European Society of Medical Oncology- Immuno Oncology Preceptorship, Singapore, November 2019
2nd Prize in Quiz competition at Best of SABCS, New Delhi ,March 2020
1st Prize at Oncology Quiz at Delhi Breast oncology Group (DBOG) meeting, May 2019, New Delhi
2nd Prize in Oncology Quiz competition at Best of WCLC, November 2019, New Delhi
3rd Prize in the Oncology Quiz organized by Max Institute of Oncology in March 2019
Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer – ANNALS OF ONCOLOGY, Volume 31, Supplement 6, November 2020, Page S1253 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https://doi.org/10.1016/j.annonc.2020.10.055
Shortcomings of immuno oncology (IO) agents application into real-world practise due to financial constraints in a resource constrained setting - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1436. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valame - https://doi.org/10.1016/j.annonc.2020.10.538
Real-world data of incidence of immune related toxicities with single agent immuno oncology drugs at a single center - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1439 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https://doi.org/10.1016/j.annonc.2020.10.545
A Prospective Study of Response Evaluation with RCHOP Therapy in DLBCL Subtypes using Hans Algorithm - Indian J Hematol Blood Transfusion (Nov 2020) 36(Suppl 1):S1–S229.
Sharat Chandra G, Pratap Kishore Das,Manish singhal, Dipanjanpanda, Atul Sharma, ShaunakValame, Amarendra Amar, Jayantpatowary - https://doi.org/10.1007/s12288-020-01384-8
A real-world scenario of applicability of immuno oncology agents into practice in NSCLC in a resource constrained setting – JOURNAL OF THORACIC ONCOLOGY, Vol. 16Issue 4S767–S768Published in issue: April, 2021. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valame - https://doi.org/10.1016/S1556-0864(21)01970-5
Primary thyroid lymphoma – A case report and its review of literature , Jan 2019 , Apollo Medicine
Oral mucositis with abiraterone acetate – a therapeutic dilemma , December 2019 , Indian journal of medical and pediatric oncology